Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer

American Journal of Reproductive Immunology

Volumn 56, Issue 3, 2006, Pages 201-214

  Braundmeier, Andrea G ^a   Nowak, Romana A ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NONE   (United States)

Author keywords

Cytokines; EMMPRIN; Endometriosis; Endometrium; Metalloproteinases

Indexed keywords

CD147 ANTIGEN; CYTOKINE; GELATINASE A; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPATHOGENESIS; IMMUNOREGULATION; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD147; CELL LINE; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746616116     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00418.x     Document Type: Article

References (63)

1. Sampson J: The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940; 40:549-557.
2. Mahmood TA, Templeton A: Prevalence and genesis of endometriosis. Hum Reprod 1991; 6:544-549.
3. Mahmood TA, Templeton AA: Minimal/mild endometriosis and infertility. Br J Obstet Gynaecol 1989; 96:1248-1249.
4. Valle RF:CEndometriosis: current concepts and therapy. Int J Gynaecol Obstet 2002; 78:107-119.
5. Witz CA, Monotoya-Rodriguez IA, Schenken RS: Whole explants of peritoneum and endometrium: A novel model of the early endometriosis lesion. Fertil Steril 1999; 71:56-60.
6. Oral E, Arici A, Olive DL, Huszar G: Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: The role of seminal fluid components. Fertil Steril 1996; 66:787-792.
7. Ho HN, Wu MY, Yang YS: Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997; 38:400-412.
8. Dunselman GA, Hendrix MG, Bouckaert PX, Evers JL: Functional aspects of peritoneal macrophages in endometriosis of women. J Reprod Fertil 1988; 82:707-710.
9. Olive DL, Weinberg JB, Haney AF: Peritoneal macrophages and infertility: the association between cell number and pelvic pathology. Fertil Steril 1985; 44:72-77.
10. Halme J: Release of tumor necrosis factor-alpha by human peritoneal macrophages in vivo and in vitro. Am J Obstet Gynecol 1989; 161:1718-1725.
11. Arici A, Senturk LM, Seli E, Bahtiyar MO, Kim G: Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 1999; 61:85-90.
12. Zeyneloglu HB, Senturk LM, Seli E, Bahtiyar OM, Olive DL, Arici A: The peritoneal fluid levels of interleukin-12 in women with endometriosis. Am J Reprod Immunol 1998; 39:152-156.
13. Fakih H, Aaggett B, Holtz G: Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987; 47:213-217.
14. Eisermann J, Gast MJ, Pineda J: Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988; 50:573-579.
15. Taketani Y, Kuo TM, Mizuno M: Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992; 167:265-270.
16. Oosterlynck D, Meuleman C, Waer M, Koninckx PR: Transforming growth factor- β activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994; 83:287-292.
17. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994; 94:946-953.
18. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993; 168:253-260.
19. Solomon A, Li D, Lee S, Tseng S: Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci 2000; 41:2154-2163.
20. Gohji K, Nomi M, Hara I, Arakawa S, Kamidono S: Influence of cytokines and growth factors on matrix metalloproteinase-2 production and invasion of human renal cancer. Urol Res 1998; 26:33-37.
21. Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y: Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 1999; 259:40-45.
22. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA: Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 1994; 79:530-536.
23. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B: Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 2001; 95:167-174.
24. Bruner KL, Eisenberg E, Gorstein F, Osteen KG: Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 1999; 64:648-653.
25. Bruner KL, Rodgers WH, Gold L, Korc M, Hargrove JT, Matrisian LM, Osteen KG: Transforming growth factor-b mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 1995; 92:7362-7366.
26. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG: Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002; 87:4782-4791.
27. Huang HY, Wen Y, Irwin JC, Kruessel JS, Soong YK, Polan ML: Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 2005; 83:1721-1729.
28. Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 2006; 91:2358-2365.
29. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C: The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 2004; 23:956-963.
30. Taylor PM, Woodfield RJ, Hodgkin MN, Pettitt TR, Martin A, Kerr DJ, Wakelam MJ: Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 2002; 21:5765-5772.
31. Strakova Z, Srisuparp S, Fazleabas AT: Interleukin-1beta induces the expression of insulin-like growth factor binding protein-1 during decidualization in the primate. Endocrinology 2000; 141:4664-4670.
32. Frank GR, Brar AK, Jikihara H, Cedars MI, Handwerger S: Interleukin 1b and the Endometrium: An Inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod 1995; 52:184-191.
33. Kessler CA, Moghadam KK, Schroeder JK, Buckley AR, Brar AK, Handwerger S: Cannaboid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol 2005; 229:65-74.
34. Richards RG, Brar AK, Grank GR, Hartman SM, Jikihara H: Fibroblast cells from term deciduas closely resemble stromal cells: Induction of prolactin and insulin-like growth factor binding protein-1 expression. Biol Reprod 1995; 52:609-615.
35. Curry TE Jr, Osteen KG: Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64:1285-1296.
36. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA, Giudice LC: Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003; 144:2870-2881.
37. Khorram O, Lessey BA: Alterations in expression of endometrial endothelial nitric oxide synthase and alpha(v)beta(3) integrin in women with endometriosis. Fertil Steril 2002; 78:860-864.
38. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B: Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 2000; 85:2526-2536.
39. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991; 56:45-51.
40. Senturk LM, Arici A: Immunology of endometriosis. J Reprod Immunol 1999; 43:67-83.
41. Zhang R, Wild R, Ojago J: Effect of tumor necrosis factor- α on adhesion of human endometrial cells to peritoneal mesothelial cells: An in vitro system. Fertil Steril 1993; 59:1196-1201.
42. Teramoto M, Kitawaki J, Koshiba H, Kitaoka Y, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Matsushita M, Maruya E, Saji H, Ohta M, Honjo H: Genetic contribution of tumor necrosis factor (TNF)-a gene promotor (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 2004; 51:352-357.
43. Gottschall P, Yu X: Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995; 64:1513-1520.
44. Vecil G, Larsen P, Corley S, Herx L, Besson A, Goodyer C, Yong V: Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 2000; 61:212-224.
45. Guo H, Li R, Zucker S, Toole BP: EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000; 60:888-891.
46. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C: Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997; 272:24-27.
47. Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, Li JD, Basbaum C: Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998; 441:88-92.
48. Muramatsu TA Miyauchi T: Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003; 18:981-987.
49. Menashi S, Serova M, Ma L, Vignot S, Mourah S, Calvo F: Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 2003; 63:7575-7580.
50. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55:434-439.
51. Tang Y, Kesavan P, NPkada MT, Yan L: Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2004; 2:73-80.
52. Siwik DA, Colucci WS: Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004; 9:43-51.
53. Gurjar MV, Deleon J, Sharma RV, Bhalla RC: Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am J Physiol Heart Circ Physiol 2001; 281:H2568-2574.
54. Lo YY, Conquer JA, Grinstein S, Cruz TF: Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: Involvement of reactive oxygen species. J Cell Biochem 1998; 69:19-29.
55. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 1989; 263:539-545.
56. Yoo HG, Shin BA, Park JS, Lee KH, Chay KO, Yang SY, Ahn BW, Jung YD: IL-1beta induces MMP-9 via reactive oxygen species and NF-kappa B in murine macrophage RAW 264.7 cells. Biochem Biophys Res Commun 2002; 298:251-256.
57. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Embo J 1987; 6:1899-1904.
58. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG: Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997; 99:2851-2857.
59. Kerr LD, Miller DB, Matrisian LM: TGF-beta 1 inhibition of transin/ stromelysin gene expression is mediated through a Fos binding sequence. Cell 1990; 61:267-278.
60. Marti HP, Lee L, Kashgarian M, Lovett DH: Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 1994; 144:82-94.
61. Moghissi KS: Medical treatment of endometriosis. Clin Obstet Gynecol 1999; 42:620-632.
62. Vercellini P, Cortesi I, Crosignani PG: Progestins for symptomatic endometriosis: A critical analysis of the evidence. Fertil Steril 1997; 68:393-401.
63. Gabison EE, Mourah S, Steinfels E, Yan L, Hoang-Xuan T, Watsky MA, De Wever B, Calvo F, Mauviel A, Menashi S: Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas. Am J Pathol 2005; 166:209-219.